Padua, L.D. et al. 2025. Efficacy of Ibrutinib in the Treatment of Monoclonal Gammopathy of Renal Significance with C3 Deposits Secondary to Chronic Lymphocytic Leukemia. Archives of Clinical and Biomedical Research. 9, 5 (Sep. 2025), 360–363.